Acute Shortage Ventilator
- SLAC
AbstractWe have implemented an “Acute Shortage Ventilator” (ASV) motivated by the COVID-19 pandemic and the possibility of severe ventilator shortages in the near future. The unit cost per ventilator is less than $400 US excluding the patient circuit parts. The ASV mechanically compresses a self-inflating bag resuscitator, uses a modified patient circuit, and is commanded by a microcontroller and an optional laptop. It operates in both Volume-Controlled Assist-Control mode and a Pressure-Controlled Assist-Control mode. It has been tested using an artificial lung against the EURS guidelines. The key design goals were to develop a simple device with high performance for short-term use, made primarily from common hospital parts and generally-available non-medical components, and at low cost and ease in manufacturing.
- Research Organization:
- SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Contributing Organization:
- Research was supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, and through Stanford University discretionary funds allocated to SLAC National Accelerator Laboratory. SLAC National Accelerator Laboratory is supported by the U.S. Department of Energy, Office of Science under Contract No. DE-AC02-76SF00515. VA Palo Alto Health Care System and Stanford University School of Medicine
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1785707
- Journal Information:
- medRxiv, Journal Name: medRxiv
- Country of Publication:
- United States
- Language:
- English
Similar Records
The novel Mechanical Ventilator Milano for the COVID-19 pandemic